Chemours (CC) PT Raised to $40 as RBC Capital Sees the Industrials Recovery Enabling Outperformance Going Forward
Tweet Send to a Friend
RBC Capital analyst Arun Viswanathan raised the price target on Chemours (NYSE: CC) to $40.00 (from $35.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
